Dijana Djureinovic
7PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 06, 2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.Sarah A Weiss, Dijana Djureinovic, Wei Wei
|Jun 21, 2023
Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.Feria Hikmet, Marc Rassy, Max Backman
|Jun 18, 2021
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel
|Jul 31, 2019
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.Dijana Djureinovic, Victor Pontén, Per Landelius
|Aug 19, 2017
A pathology atlas of the human cancer transcriptome.Mathias Uhlen, Cheng Zhang, Sunjae Lee
|Jul 01, 2017
PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability.Hans Brunnström, Anna Johansson, Sofia Westbom-Fremer
Pageof 2
Frequent Collaborators
2 joint publications
Amit Mahajan
2 joint publications
Cecilia Lindskog
1 joint publications
Mathias Uhlen
1 joint publications
Cheng Zhang
1 joint publications
Sunjae Lee
1 joint publications
Evelina Sjöstedt
1 joint publications
Linn Fagerberg
1 joint publications
Gholamreza Bidkhori
1 joint publications
Harriet M Kluger
1 joint publications
Muhammad Arif
